Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Validated model of platelet slip at stenosis and device surfaces.

Denardo SJ, Denardo BC, Carpinone PL, Dean WT, New DM, Estrada LE, Green CL, Yock PG, Karunasiri G.

Platelets. 2019 Jul 17:1-10. doi: 10.1080/09537104.2019.1636021. [Epub ahead of print]

PMID:
31311384
2.

Early invasive assessment of the coronary microcirculation predicts subsequent acute rejection after heart transplantation.

Okada K, Honda Y, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Khush KK, Fearon WF.

Int J Cardiol. 2019 Sep 1;290:27-32. doi: 10.1016/j.ijcard.2019.04.018. Epub 2019 Apr 8.

PMID:
30987835
3.

Bioresorbable Scaffold for Treatment of Coronary Artery Lesions: Intravascular Ultrasound Results From the ABSORB Japan Trial.

Okada K, Honda Y, Kitahara H, Otagiri K, Tanaka S, Hollak MB, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Kimura T; ABSORB Japan Investigators.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):648-661. doi: 10.1016/j.jcin.2017.11.034.

4.

Impact of Stent Size Selection on Acute and Long-Term Outcomes After Drug-Eluting Stent Implantation in De Novo Coronary Lesions.

Kitahara H, Okada K, Kimura T, Yock PG, Lansky AJ, Popma JJ, Yeung AC, Fitzgerald PJ, Honda Y.

Circ Cardiovasc Interv. 2017 Oct;10(10). pii: e004795. doi: 10.1161/CIRCINTERVENTIONS.116.004795.

PMID:
28951394
5.

Assessment of bioresorbable scaffold with a novel high-definition 60 MHz IVUS imaging system: Comparison with 40-MHz IVUS referenced to optical coherence tomography.

Okada K, Kitahara H, Mitsutake Y, Tanaka S, Kimura T, Yock PG, Fitzgerald PJ, Ikeno F, Honda Y.

Catheter Cardiovasc Interv. 2018 Apr 1;91(5):874-883. doi: 10.1002/ccd.27197. Epub 2017 Jul 14.

PMID:
28707349
6.

Needs-Based Innovation in Interventional Radiology: The Biodesign Process.

Steinberger JD, Denend L, Azagury DE, Brinton TJ, Makower J, Yock PG.

Tech Vasc Interv Radiol. 2017 Jun;20(2):84-89. doi: 10.1053/j.tvir.2017.04.006. Epub 2017 Apr 18.

PMID:
28673651
7.

The effect of negative remodeling on fractional flow reserve after cardiac transplantation.

Fearon WF, Felix R, Hirohata A, Sakurai R, Jose PO, Yamasaki M, Nakamura M, Fitzgerald PJ, Valantine HA, Yock PG, Yeung AC.

Int J Cardiol. 2017 Aug 15;241:283-287. doi: 10.1016/j.ijcard.2017.04.020. Epub 2017 Apr 8.

PMID:
28413112
8.

Impact of attenuated-signal plaque observed by intravascular ultrasound on vessel response after drug-eluting stent implantation.

Kitahara H, Waseda K, Sakamoto K, Yamada R, Huang CC, Nakatani D, Sakata K, Kawarada O, Yock PG, Matsuyama Y, Yokoi H, Nakamura M, Muramatsu T, Nanto S, Fitzgerald PJ, Honda Y.

Atherosclerosis. 2017 Apr;259:68-74. doi: 10.1016/j.atherosclerosis.2017.02.009. Epub 2017 Feb 20.

PMID:
28327450
9.

The Impact of Postgraduate Health Technology Innovation Training: Outcomes of the Stanford Biodesign Fellowship.

Wall J, Hellman E, Denend L, Rait D, Venook R, Lucian L, Azagury D, Yock PG, Brinton TJ.

Ann Biomed Eng. 2017 May;45(5):1163-1171. doi: 10.1007/s10439-016-1777-1. Epub 2016 Dec 21.

10.

Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process.

Schwartz JG, Kumar UN, Azagury DE, Brinton TJ, Yock PG.

JACC Basic Transl Sci. 2016 Oct 31;1(6):541-547. doi: 10.1016/j.jacbts.2016.06.011. eCollection 2016 Oct. Review.

11.

Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.

Okada K, Fearon WF, Luikart H, Kitahara H, Otagiri K, Tanaka S, Kimura T, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Khush KK, Honda Y.

J Am Coll Cardiol. 2016 Jul 26;68(4):382-92. doi: 10.1016/j.jacc.2016.05.028.

12.

Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part II. In Vivo Imaging of Bone Marrow Stromal Cells in Swine with PET/CT and MR Imaging.

Parashurama N, Ahn BC, Ziv K, Ito K, Paulmurugan R, Willmann JK, Chung J, Ikeno F, Swanson JC, Merk DR, Lyons JK, Yerushalmi D, Teramoto T, Kosuge H, Dao CN, Ray P, Patel M, Chang YF, Mahmoudi M, Cohen JE, Goldstone AB, Habte F, Bhaumik S, Yaghoubi S, Robbins RC, Dash R, Yang PC, Brinton TJ, Yock PG, McConnell MV, Gambhir SS.

Radiology. 2016 Sep;280(3):826-36. doi: 10.1148/radiol.2016151150. Epub 2016 Jun 22.

13.

Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part I. Reporter Gene Design, Characterization, and Optical in Vivo Imaging of Bone Marrow Stromal Cells after Myocardial Infarction.

Parashurama N, Ahn BC, Ziv K, Ito K, Paulmurugan R, Willmann JK, Chung J, Ikeno F, Swanson JC, Merk DR, Lyons JK, Yerushalmi D, Teramoto T, Kosuge H, Dao CN, Ray P, Patel M, Chang YF, Mahmoudi M, Cohen JE, Goldstone AB, Habte F, Bhaumik S, Yaghoubi S, Robbins RC, Dash R, Yang PC, Brinton TJ, Yock PG, McConnell MV, Gambhir SS.

Radiology. 2016 Sep;280(3):815-25. doi: 10.1148/radiol.2016140049. Epub 2016 Jun 16.

14.

Acute stent recoil and optimal balloon inflation strategy: an experimental study using real-time optical coherence tomography.

Kitahara H, Waseda K, Yamada R, Otagiri K, Tanaka S, Kobayashi Y, Okada K, Kume T, Nakagawa K, Teramoto T, Ikeno F, Yock PG, Fitzgerald PJ, Honda Y.

EuroIntervention. 2016 Jun 12;12(2):e190-8. doi: 10.4244/EIJV12I2A32.

15.

Functional Versus Anatomic Assessment of Myocardial Bridging by Intravascular Ultrasound: Impact of Arterial Compression on Proximal Atherosclerotic Plaque.

Yamada R, Tremmel JA, Tanaka S, Lin S, Kobayashi Y, Hollak MB, Yock PG, Fitzgerald PJ, Schnittger I, Honda Y.

J Am Heart Assoc. 2016 Apr 20;5(4):e001735. doi: 10.1161/JAHA.114.001735.

16.

Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients.

Kitahara H, Okada K, Tanaka S, Yang HM, Miki K, Kobayashi Y, Kimura T, Luikart H, Yock PG, Yeung AC, Fitzgerald PJ, Khush KK, Fearon WF, Honda Y.

J Heart Lung Transplant. 2016 Jun;35(6):752-9. doi: 10.1016/j.healun.2016.02.002. Epub 2016 Mar 10.

17.

Relative dose and vascular response after drug-eluting stent implantation: A dosimetric 3D-intravascular ultrasound study.

Kitahara H, Waseda K, Yamada R, Sakamoto K, Yock PG, Fitzgerald PJ, Honda Y.

Int J Cardiol. 2016 Feb 1;204:211-7. doi: 10.1016/j.ijcard.2015.11.130. Epub 2015 Nov 30.

PMID:
26681540
18.

Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation.

Okada K, Kitahara H, Yang HM, Tanaka S, Kobayashi Y, Kimura T, Luikart H, Yock PG, Yeung AC, Valantine HA, Fitzgerald PJ, Khush KK, Honda Y, Fearon WF.

JACC Heart Fail. 2015 Dec;3(12):942-52. doi: 10.1016/j.jchf.2015.07.013. Epub 2015 Nov 11.

19.

Quantitative precision of optical frequency domain imaging: direct comparison with frequency domain optical coherence tomography and intravascular ultrasound.

Kobayashi Y, Kitahara H, Tanaka S, Okada K, Kimura T, Ikeno F, Yock PG, Fitzgerald PJ, Honda Y.

Cardiovasc Interv Ther. 2016 Apr;31(2):79-88. doi: 10.1007/s12928-015-0349-x. Epub 2015 Aug 14.

20.

A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial.

Sakata K, Koo BK, Waseda K, Nakatani D, Yock PG, Whitbourn R, Worthley SG, Ormiston J, Webster M, Wilkins GT, Honda Y, Meredith IT, Fitzgerald PJ.

EuroIntervention. 2015 Mar 22;10(11):e1-8. doi: 10.4244/EIJY14M08_16.

21.

A Mechanomodulatory Device to Minimize Incisional Scar Formation.

Wong VW, Beasley B, Zepeda J, Dauskardt RH, Yock PG, Longaker MT, Gurtner GC.

Adv Wound Care (New Rochelle). 2013 May;2(4):185-194.

22.

Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy.

Sasportas LS, Hosford DN, Sodini MA, Waters DJ, Zambricki EA, Barral JK, Graves EE, Brinton TJ, Yock PG, Le QT, Sirjani D.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jul;116(1):e37-51. doi: 10.1016/j.oooo.2013.02.017. Epub 2013 May 3. Review.

23.

Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial.

Kume T, Waseda K, Koo BK, Yock PG, Botelho R, Verheye S, Whitbourn R, Meredith I, Worthley S, Hai KT, Honda Y, Abizaid A, Fitzgerald PJ.

Catheter Cardiovasc Interv. 2014 Jan 1;83(1):19-24. doi: 10.1002/ccd.24867. Epub 2013 Mar 16.

PMID:
23413202
24.

Outcomes from a postgraduate biomedical technology innovation training program: the first 12 years of Stanford Biodesign.

Brinton TJ, Kurihara CQ, Camarillo DB, Pietzsch JB, Gorodsky J, Zenios SA, Doshi R, Shen C, Kumar UN, Mairal A, Watkins J, Popp RL, Wang PJ, Makower J, Krummel TM, Yock PG.

Ann Biomed Eng. 2013 Sep;41(9):1803-10. doi: 10.1007/s10439-013-0761-2. Epub 2013 Feb 13.

25.

Gastroenterology and biodesign: contributing to the future of our specialty.

Nimgaonkar A, Yock PG, Brinton TJ, Krummel T, Pasricha PJ.

Gastroenterology. 2013 Feb;144(2):258-62. doi: 10.1053/j.gastro.2012.12.009. Epub 2012 Dec 12. Review. No abstract available.

PMID:
23246636
26.

Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses.

Sakata K, Waseda K, Kume T, Otake H, Nakatani D, Yock PG, Fitzgerald PJ, Honda Y.

Circ Cardiovasc Interv. 2012 Dec;5(6):763-71. doi: 10.1161/CIRCINTERVENTIONS.111.962878. Epub 2012 Nov 13.

PMID:
23149332
27.

Intravascular ultrasound comparison of small coronary lesions between novel guidewire-based sirolimus-eluting stents and conventional sirolimus-eluting stents.

Kume T, Waseda K, Koo BK, Botelho R, Verheye S, Whitbourn R, Meredith I, Worthley S, Hai KT, Yock PG, Azevedo de Oliveira FR, Abizaid A, Fitzgerald PJ, Honda Y.

J Invasive Cardiol. 2012 Oct;24(10):489-93.

28.

Applying a structured innovation process to interventional radiology: a single-center experience.

Sista AK, Hwang GL, Hovsepian DM, Sze DY, Kuo WT, Kothary N, Louie JD, Yamada K, Hong R, Dhanani R, Brinton TJ, Krummel TM, Makower J, Yock PG, Hofmann LV.

J Vasc Interv Radiol. 2012 Apr;23(4):488-94. doi: 10.1016/j.jvir.2011.12.029.

PMID:
22464713
29.

Three-dimensional microstructural changes in murine abdominal aortic aneurysms quantified using immunofluorescent array tomography.

Saatchi S, Azuma J, Wanchoo N, Smith SJ, Yock PG, Taylor CA, Tsao PS.

J Histochem Cytochem. 2012 Feb;60(2):97-109. doi: 10.1369/0022155411433066. Epub 2011 Dec 1. Review.

30.

Improved automated lumen contour detection by novel multifrequency processing algorithm with current intravascular ultrasound system.

Kume T, Kim BK, Waseda K, Sathyanarayana S, Li W, Teo TJ, Yock PG, Fitzgerald PJ, Honda Y.

Catheter Cardiovasc Interv. 2013 Feb;81(3):E173-7. doi: 10.1002/ccd.23274. Epub 2011 Sep 26.

PMID:
21805600
31.

Sex differences in neointimal hyperplasia following endeavor zotarolimus-eluting stent implantation.

Nakatani D, Ako J, Tremmel JA, Waseda K, Otake H, Koo BK, Miyazawa A, Hongo Y, Hur SH, Sakurai R, Yock PG, Honda Y, Fitzgerald PJ.

Am J Cardiol. 2011 Oct 1;108(7):912-7. doi: 10.1016/j.amjcard.2011.05.019. Epub 2011 Jul 23.

PMID:
21784390
32.

Teaching biomedical technology innovation as a discipline.

Yock PG, Brinton TJ, Zenios SA.

Sci Transl Med. 2011 Jul 20;3(92):92cm18. doi: 10.1126/scitranslmed.3002222. Review.

PMID:
21775665
33.

Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy: new findings by three-dimensional intravascular ultrasound analysis.

Yamasaki M, Sakurai R, Hirohata A, Honda Y, Bonneau HN, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Fearon WF.

Transplantation. 2011 Jun 27;91(12):1406-11. doi: 10.1097/TP.0b013e31821ab91b.

PMID:
21512436
34.

Preprocedural inflammation does not affect neointimal hyperplasia following everolimus-eluting stent implantation.

Nakatani D, Ako J, Yamasaki M, Shimohama T, Hasegawa T, Otake H, Waseda K, Tsujino I, Sakurai R, Koo BK, Chang H, Yock PG, Sudhir K, Pierson W, Stone GW, Saito S, Honda Y, Fitzgerald PJ.

J Invasive Cardiol. 2009 Dec;21(12):613-7.

35.

Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.

Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ; ENDEAVOR IV Trial Investigators.

JACC Cardiovasc Interv. 2009 Aug;2(8):779-84. doi: 10.1016/j.jcin.2009.05.015.

36.

In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation.

Suzuki Y, Ikeno F, Koizumi T, Tio F, Yeung AC, Yock PG, Fitzgerald PJ, Fearon WF.

JACC Cardiovasc Interv. 2008 Apr;1(2):168-73. doi: 10.1016/j.jcin.2007.12.007.

37.

Intraoperative fluorescence imaging system for on-site assessment of off-pump coronary artery bypass graft.

Waseda K, Ako J, Hasegawa T, Shimada Y, Ikeno F, Ishikawa T, Demura Y, Hatada K, Yock PG, Honda Y, Fitzgerald PJ, Takahashi M.

JACC Cardiovasc Imaging. 2009 May;2(5):604-12. doi: 10.1016/j.jcmg.2008.12.028.

38.

Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial.

Kaneda H, Ako J, Terashima M, Morino Y, Honda Y, Yock PG, Leon MB, Moses JW, Fitzgerald PJ; SIRIUS Investigators.

Int J Cardiol. 2010 Jan 21;138(2):126-30. doi: 10.1016/j.ijcard.2008.08.006. Epub 2008 Sep 19.

PMID:
18804877
39.

Transcriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality.

Wilson KD, Li Z, Wagner R, Yue P, Tsao P, Nestorova G, Huang M, Hirschberg DL, Yock PG, Quertermous T, Wu JC.

PLoS One. 2008 Jul 9;3(7):e2609. doi: 10.1371/journal.pone.0002609.

40.

Distribution pattern of neointimal hyperplasia following sirolimus-eluting stent implantation assessed by 3-dimensional intravascular ultrasound.

Kaneda H, Ako J, Terashima M, Waseda K, Yock PG, Fitzgerald PJ.

Int J Cardiol. 2009 Jun 26;135(2):243-5. doi: 10.1016/j.ijcard.2008.01.054. Epub 2008 Jun 20.

PMID:
18571251
41.

Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction.

Fearon WF, Shah M, Ng M, Brinton T, Wilson A, Tremmel JA, Schnittger I, Lee DP, Vagelos RH, Fitzgerald PJ, Yock PG, Yeung AC.

J Am Coll Cardiol. 2008 Feb 5;51(5):560-5. doi: 10.1016/j.jacc.2007.08.062.

42.

Determinants of lumen loss between years 1 and 2 after cardiac transplantation.

Sakurai R, Yamasaki M, Nakamura M, Hirohata A, Honda Y, Bonneau HN, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Fearon WF.

Transplantation. 2007 Nov 15;84(9):1097-102.

PMID:
17998863
43.

Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial).

Sakurai R, Hongo Y, Yamasaki M, Honda Y, Bonneau HN, Yock PG, Cutlip D, Popma JJ, Zimetbaum P, Fajadet J, Kuntz RE, Wijns W, Fitzgerald PJ; ENDEAVOR II Trial Investigators.

Am J Cardiol. 2007 Sep 1;100(5):818-23. Epub 2007 Jun 14.

PMID:
17719326
44.

Neointimal progression and luminal narrowing in sirolimus-eluting stent treatment for bare metal in-stent restenosis: a quantitative intravascular ultrasound analysis.

Sakurai R, Ako J, Hassan AH, Bonneau HN, Neumann FJ, Desmet W, Holmes DR Jr, Yock PG, Fitzgerald PJ, Honda Y.

Am Heart J. 2007 Aug;154(2):361-5.

PMID:
17643589
45.

Changes in coronary anatomy and physiology after heart transplantation.

Hirohata A, Nakamura M, Waseda K, Honda Y, Lee DP, Vagelos RH, Hunt SA, Valantine HA, Yock PG, Fitzgerald PJ, Yeung AC, Fearon WF.

Am J Cardiol. 2007 Jun 1;99(11):1603-7. Epub 2007 Apr 19.

46.

Serial intravascular ultrasonic study of outcomes of coronary culprit lesions with plaque rupture following bare metal stent implantation in patients with angina pectoris.

Hur SH, Hassan AH, Rekhi R, Ako J, Shimada Y, Nakamura M, Yamasaki M, Bonneau HN, Sudhir K, Yock PG, Honda Y, Fitzgerald PJ.

Am J Cardiol. 2007 May 15;99(10):1394-8. Epub 2007 Mar 28.

PMID:
17493467
47.

Comparison of vessel response following sirolimus-eluting stent implantation as assessed by serial 3-D intravascular ultrasound study.

Waseda K, Ako J, Shimada Y, Morino Y, Tsujino I, Hongo Y, Sudhir K, Yock PG, Fitzgerald PJ, Honda Y.

J Invasive Cardiol. 2007 Apr;19(4):171-3.

PMID:
17404402
48.

Coronary risk factors and coronary atheroma burden at severely narrowing segments.

Kaneda H, Kataoka T, Ako J, Honda Y, Yock PG, Fitzgerald PJ.

Int J Cardiol. 2008 Feb 20;124(1):124-6. Epub 2007 Mar 12.

PMID:
17350700
49.

Impact of gender on neointimal hyperplasia following coronary artery stenting.

Kaneda H, Ako J, Kataoka T, Takahashi T, Terashima M, Waseda K, Miyazawa A, Hassan AH, Honda Y, Yock PG, Fitzgerald PJ.

Am J Cardiol. 2007 Feb 15;99(4):491-3. Epub 2006 Dec 21.

PMID:
17293191
50.

Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial).

Hirohata A, Morino Y, Ako J, Sakurai R, Buchbinder M, Caputo RP, Karas SP, Mishkel GJ, Mooney MR, O'shaughnessy CD, Raizner AE, Wilensky RL, Williams DO, Wong SC, Yock PG, Honda Y, Moses JW, Fitzgerald PJ; DIRECT Investigators.

Am J Cardiol. 2006 Dec 1;98(11):1464-7. Epub 2006 Oct 12.

PMID:
17126651

Supplemental Content

Support Center